Metronidazole,clotrimazole and chlorhexidime acetate vaginal effervescent tablet and preparation technique
A technology for effervescent tablet and bisazotide, which is applied to the field of vaginal effervescent tablet and its preparation, can solve the problems of uneasy production, unqualified friability, unqualified tablet properties, etc. , the effect of not easy to operate
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0020] Shuangzotai vaginal effervescent tablets, each containing the following components: Metronidazole 0.2g, clotrimazole 0.16g, chlorhexidine acetate 0.008g, sodium bicarbonate 0.115g, tartaric acid 0.125g, lactose 0.15g, ten Dialkyl sodium sulfate 0.02g, micropowder silica gel 0.03g, calcium hydrogen phosphate 0.015g, magnesium stearate 0.0055g, 95% ethanol 0.12g, povidone K30: 0.005g.
[0021] The preparation technology of described Shuangzotai effervescent tablet comprises the following steps:
[0022] a) pulverize metronidazole, clotrimazole, chlorhexidine acetate and other auxiliary materials respectively, and cross 80 mesh sieves for subsequent use;
[0023] b) Weighing various raw and auxiliary materials according to the ratio;
[0024] c) 5 grams of Povidone K30 are dissolved in 95 grams of 95% ethanol to prepare 5% and Povidone K30 aqueous solution;
[0025] d) Metronidazole and tartaric acid are prepared with an appropriate amount of absolute ethanol to make sof...
Embodiment 2
[0030] In addition to Shuangzotai vaginal effervescent tablets, each tablet contains the following components: metronidazole 0.2g, clotrimazole 0.16g, chlorhexidine acetate 0.008g, sodium bicarbonate 0.08g, tartaric acid 0.1g, lactose 0.1g, Sodium lauryl sulfate 0.015g, micropowder silica gel 0.01g, calcium hydrogen phosphate 0.01g, magnesium stearate 0.005g, 95% ethanol 0.09g, povidone K30: 0.004g;
Embodiment 3
[0032] In addition to Shuangzotai vaginal effervescent tablets, each tablet contains the following components: metronidazole 0.2g, clotrimazole 0.16g, chlorhexidine acetate 0.008g, sodium bicarbonate 0.15g, tartaric acid 0.15g, lactose 0.20g, Sodium lauryl sulfate 0.035g, micropowder silica gel 0.05g, calcium hydrogen phosphate 0.02g, magnesium stearate 0.006g, 95% ethanol 0.15g, povidone K30: 0.006g;
[0033] Embodiments 1, 2, and 3 do not have sticking phenomenon in the tableting process, and it is not easy to operate during production; there is no bag swelling phenomenon after packaging, and Embodiment 1, 2, and 3 are placed at room temperature for 3 years. The foaming volume is 10ml, 12ml, 15ml respectively.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com